OOIR: Observatory of International Research

Papers

(The median citation count of Journal of Benefit-Cost Analysis is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
A Benefit–Cost Analysis of Tulsa Pre-K, Based on Effects on High-School Graduation and College Attendance	25
Cost–Benefit Analysis of Bus Fare Subsidies under Financial Constraints: The Case of Asunción, Paraguay	19
Funding a Just Transition Away from Coal in the U.S. Considering Avoided Damage from Air Pollution	17
Economic Evaluation Under Ambiguity and Structural Uncertainties	17
A Tale of the Tails: The Value of a Statistical Life at the Tails of the Age Distribution	17
Benefit–cost analysis in the 5.9 GHz band	16
Regulatory Impact Analysis and Litigation Risk	15
Be Brief, Be Consistent, Be Neutral: Comments on US Draft Circular A-4, “Regulatory Analysis”	13
Mask Mandate Costs	12
Why Office of Management and Budget’s (OMB) Social Welfare Function Is Not Society’s Social Welfare Function	12
When Can Benefit–Cost Analyses Ignore Secondary Markets?	10
A Benefit-Cost Analysis of Increased International Migration of Skilled Labor in Africa and the World	10
From Benefit–Cost Analysis to Social Welfare: A Pragmatic Approach	10
Comparing the Draft and Final Circular A-4	9
Valuing a Reduction in the Risk of Chronic Kidney Disease: A Large-Scale Multi-Country Stated Preference Approach	9
Introduction to the Special Issue	7
Social Welfare Functions and Health Policy: A New Approach	7
BCA volume 15 issue 3 Cover and Front matter	6
The Incomparable Jerry Ellig	6
Do Opportunity Costs of Regulations Appropriately Benefit or Inappropriately Burden Disadvantaged Consumers?	6
Is Communications-Company Ownership of Video Content a Threat to Competition?	5
Distribution and Disputation: Net Benefits, Equity, and Public Decision-Making	5
The Global Burden of the COVID-19 Pandemic: Comparing Benefit–Cost Analysis and Social Welfare Analysis	5
Assessing Risk, Effectiveness, and Benefits in Transportation Regulation	5
Ex-Ante Analysis of the Costs and Benefits of Legalizing Cannabis Markets in the Czech Republic	5

Benefit–Cost Analysis of Increased Trade: An Order-of-Magnitude Estimate of the Benefit–Cost Ratio	5
What OIRA Peer Reviewers Advised Regarding Notable Proposed Updates to Circular A-4: An Ignored Consensus?	4
Valuing a Reduction in the Risk and Severity of Asthma: A Large Scale Multi-Country Stated Preference Approach	4
Best Investments in Chronic, Noncommunicable Disease Prevention and Control in Low- and Lower–Middle-Income Countries – CORRIGENDUM	3
Advice on Guidance: Peer Review of Draft Circular A-4 “Regulatory Analysis”	3
The Elasticity of Marginal Utility of Income for Distributional Weighting and Social Discounting: A Meta-Analysis	3
BCA volume 16 issue S2 Cover and Front matter	3
BCA volume 14 issue 1 Cover and Front matter	2
Efficiency vs. Welfare in Benefit–Cost Analysis: The Case of Government Funding	2
Applying the Regulatory Report Card to Tax Regulations	2
Don’t TREAD on Anyone? The Political Economy and Effectiveness of Tire Pressure Monitoring Systems	2
Investing in Nutrition: A Global Best Investment Case	2
Sustainable Development Goal Halftime Project: Benefit-Cost Analysis Using Methods from the Decade of Vaccine Economics Model	2
Letter from Former SBCA Presidents and JBCA Editors to OIRA Administrator	2
Application of an Epi-Econ-Model to Analyze COVID-19 Lockdown Policies in the Netherlands: Lessons and Limitations	2
Citizen Preferences and BCA: A Model of Willingness-to-Pay behind a Veil of Ignorance	1
The Health-Augmented Lifecycle Model – CORRIGENDUM	1
Lessons to Be Learned from Impact Assessments in Times of Crises: A Qualitative Analysis of Finnish Law-Drafting during COVID-19	1
An Assessment of the Climate Damage Costs of European Short-Lived Climate Forcers	1
The Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Model for Measuring the Value of Gains in Health: An Exact Formulation	1
Valuing Heat-Related Mortality Risks	1
The Net Benefits and Residual Cost from U.S. Border Management of the Initially Inadmissible	1
BCA volume 14 issue S1 Cover and Front matter	1
BCA volume 16 issue 1 Cover and Front matter	0
Reorganization of Economists at the FCC: The Role of Decision Rights, Control Systems, and Culture	0
Ethics and Benefit–Cost Analysis: Introduction to the Special Issue	0
BCA volume 16 issue S1 Cover and Front matter	0
An Equity Blindspot: The Incidence of Regulatory Costs	0
Discounting in Natural Resource Damage Assessment	0
BCA volume 15 issue S1 Cover and Front matter	0
Regulators Should Value Nonhuman Animals	0
Policy Diffusion, Environmental Federalism, and Economic Efficiency – How Institutions Influence the Implementation of EU Legislation in Two Nordic Countries	0
Viscusi Circular A-4 Peer Review Comments and Guidance for Future Revisions	0
Adaptable Tool for Modeling the Benefits and Costs of Substance Use Disorder Recovery Programs	0
Save 4.2 Million Lives and Generate $1.1 Trillion in Economic Benefits for Only $41 Billion: Introduction to the Special Issue on the Most Efficient Policies for the Sustainable Development Goals	0
Open Exceptions: Why Does the Brazilian Health Regulatory Agency (ANVISA) Exempts RIA and Ex Post Reviews?	0
BCA volume 16 issue S1 Cover and Back matter	0
Benefit–Cost Analysis of Increased Funding for Agricultural Research and Development in the Global South	0
The Costs and Benefits of a Local DNA Database	0
The Economic Benefit of Recycling: An Application of Travel Cost Method to Estimate the Consumer Surplus	0
Improving Learning in Low- and Lower-Middle-Income Countries	0
Promoting Equity through Equitable Risk Tradeoffs	0
The Investment Case for Land Tenure Security in Sub-Saharan Africa: A Cost–Benefit Analysis	0
Inequality and the Value of a Statistical Life	0
Ensuring Durability and Objectivity in Regulatory Analysis: Comments on OMB Circular A-4	0
When Patients are Assailants: Valuing Occupational Risks in Health Care	0
Monetizing Animal Welfare Impacts for Benefit–Cost Analysis	0
Discounting in Natural Resource Damage Assessment – Erratum	0
An Ancillary Effect of Patient Navigation Following Detox: Fewer Arrests	0
Achieving Maternal and Neonatal Mortality Development Goals Effectively: A Cost-Benefit Analysis	0

What Are the Effects of Early Childhood Exposure to Environmental Lead on Personality?	0
Renewable Energy Support Through Feed-in Tariffs: A Retrospective Stakeholder Analysis	0
BCA volume 14 issue 3 Cover and Front matter	0
Forecast Errors and Welfare Conclusions Based on the Flyvbjerg Database	0
BCA volume 14 issue 2 Cover and Front matter	0
Ex Ante Costs Versus Ex Post Costs of the Large Municipal Waste Combustor Rule	0
The Value of Life in the Social Cost of Carbon: A Critique and a Proposal	0
Cost–Benefit Analysis of an “Average” Professional Sports Team or Stadium in the United States	0
The Health-Augmented Lifecycle Model	0
BCA volume 16 issue 2-3 Cover and Front matter	0
The Influence of the Benefit–Cost Analysis on Policy Evaluation in the European Union	0
BCA volume 15 issue 2 Cover and Front matter	0
The Coordination Value of Regulation	0
Guidance Is Not Enough: U.S. Circular A-4, “Regulatory Analysis”	0
Regulatory Impact Analysis Guidelines: Introduction to Special Issue	0
An Investment Case for the Scale-up and Use of Insecticide-Treated Nets Halfway into the SDG Targets	0
Estimated Values of Avoiding Cancer Risks by Cancer Site and Population	0
The Shadow Prices of Voluntary Caregiving: Using Well-Being Panel Data to Estimate the Cost of Informal Care	0
A Test of Hirschman’s Hiding Hand Principle in World Bank-Financed Hydropower Projects	0
All Cancers Are not Created Equal: How Do Survival Prospects Affect the Willingness to Pay to Avoid Cancer?	0
Specifying the Baseline in Benefit–Cost Analysis: Comments on U.S. Draft Circular A4	0
The Right Numeraire or the Just Weights? How to Make BCA Rational and Fair	0
One Million Lives Saved Per Year: A Cost–Benefit Analysis of the Global Plan to End Tuberculosis, 2023–2030 and Beyond	0
The Welfare Cost of Beijing’s Lottery Policy: Evidence from a Contingent Valuation Survey	0
“What’s Your Problem?”: Building an Evidence-Based System of Regulatory Analysis from the Bottom-Up	0
Lessons from Applying Value of Statistical Life and Alternate Methods to Benefit–Cost Analysis to Inform Development Spending	0
Economic Efficiency-Based Benefit–Cost Analysis: Comments on Circular A-4	0
On the Design of a Regulatory System	0
BCA volume 15 issue S1 Cover and Back matter	0
Regulatory Reform: Results and Challenges	0
BCA volume 15 issue 1 Cover and Front matter	0
The Military VSL	0
Redistributive Regulations and Deadweight Loss	0
Differences by Race and Ethnicity in Title IX’s Effect on Women’s Health	0
Best Investments in Chronic, Noncommunicable Disease Prevention and Control in Low- and Lower–Middle-Income Countries	0
Revision of Circular A-4 Is Warranted to Reflect the Advances in Scholarship Relevant to Regulatory Analysis, but Some Caveats Are in Order	0
Sustainable Development Goal Halftime Project: Benefit-Cost Analysis Using Methods from the Decade of Vaccine Economics Model – CORRIGENDUM	0
Estimating Lost Dividends from Incomplete Energy Access Transitions	0
Seven Recommendations for Pricing Greenhouse Gas Emissions	0
The Investment Case for E-Government Procurement: A Cost–Benefit Analysis	0
Distributional weighting and welfare/equity tradeoffs: a new approach	0